mupirocin and isosorbide-5-mononitrate

mupirocin has been researched along with isosorbide-5-mononitrate* in 1 studies

Other Studies

1 other study(ies) available for mupirocin and isosorbide-5-mononitrate

ArticleYear
Mechanistic studies of the antibiofilm activity and synergy with antibiotics of isosorbide mononitrate.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Mar-30, Volume: 115

    The use of nitric oxide (NO), a naturally occurring antimicrobial agent, as an alternative strategy to combat bacterial biofilms has recently gained considerable momentum in light of the global threat of emerging antibiotic resistance. While previous NO-based anti-biofilm approaches were aimed at killing bacterial cells within biofilms, NO has also been recently identified as a key mediator of biofilm dispersal, causing the release of cells from the biofilm community. This is of great interest towards the design of more effective anti-biofilm strategies but further studies are warranted to validate this concept. Therefore, in the present study we investigated whether a NO precursor, isosorbide mononitrate (ISMN) or its analogue D-isosorbide can induce bacteria cell dispersal from Staphylococcus aureus (S. aureus) biofilms and explored the potential synergy of ISMN and the antimicrobial compounds mupirocin and ciprofloxacin in biofilm eradication. This study demonstrate that ISMN causes dispersal of S. aureus biofilm bacteria, particularly when exposed to high levels of drug. ISMN at 60mg/mL increased the number of colony forming units (CFU) (~3log

    Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Isosorbide Dinitrate; Microbial Sensitivity Tests; Mupirocin; Nitric Oxide; Plankton; Staphylococcal Infections; Staphylococcus aureus

2018